Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study

Fig. 4

HCC-SM CMU score chart. Each patient’s predicted survival probabilities at each clinically relevant time point (3, 6, and 12 months) classified into five risk groups with a specific coloring label as follows: 81–100% (green), 61–80% (yellow), 41–60% (light orange), 21–40% (dark orange), and 0–20% (pink). Abbreviation: KPS, Karnofsky Performance Status

Back to article page